Pasithea Therapeutics Corp.
NASDAQ: KTTAW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Tiago Reis Marques
- Employees
- 4
- Headquarters
- Miami Beach, United States
- IPO year
- 2021
- Market cap
- $40.9K
- Website
- http://pasitheaclinics.com
Loading KTTAW…
Loading profile data…Frequently asked questions about KTTAW
What does Pasithea Therapeutics Corp. (KTTAW) do?
Pasithea Therapeutics Corp. is a biotechnology firm dedicated to exploring and developing therapies for various psychiatric and neurological conditions. Beyond its research endeavors, the company intends to establish clinics specializing in the treatment of depression. At these facilities, certified pharmacists will administer intravenous ketami...
Where does KTTAW trade?
Pasithea Therapeutics Corp. (KTTAW) trades on the NASDAQ Capital Market.
What sector is KTTAW in?
Pasithea Therapeutics Corp. (KTTAW) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Pasithea Therapeutics Corp.?
Tiago Reis Marques is the chief executive officer of Pasithea Therapeutics Corp. (KTTAW).
Where is Pasithea Therapeutics Corp. headquartered?
Pasithea Therapeutics Corp. is headquartered in United States.
Does KTTAW pay a dividend?
Pasithea Therapeutics Corp. (KTTAW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did KTTAW go public?
Pasithea Therapeutics Corp. (KTTAW) completed its initial public offering in 2021.